瘤透淋巴细胞疗法景观:前景和挑战
Ruqin Chen1, Jeffrey Johnson2, Ali Rezazadeh3
1Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
BMJ oncology
|August 6, 2025
概括
瘤透淋巴细胞 (TIL) 治疗是一种用于固体瘤的新型采用细胞转移. 最近的FDA批准意味着进展,但毒性和制造复杂性等挑战仍然存在,推动研究改进战略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 瘤透淋巴细胞 (TIL) 疗法在固体瘤的采用细胞转移方面取得了重大进展.
- 美国食品和药物管理局对lifileucel的加速批准强调了TIL疗法的日益增长的临床相关性.
- 本综述综合了目前对TIL治疗的理解,包括其历史,生物基础和临床影响.
研究的目的:
- 为提供瘤透性淋巴细胞 (TIL) 治疗的全面审查.
- 检查TIL治疗的历史发展,生物机制,临床疗效,安全性和局限性.
- 探索TIL制造的进步以及克服当前挑战的新兴策略.
主要方法:
- 关于TIL治疗的综合文献综述.
- 分析历史数据,临床试验结果和生物研究.
- 检查制造技术,基因改造和新的治疗方法.
主要成果:
- TIL疗法在治疗固体瘤方面表现有前途,而lifileucel最近获得FDA批准是关键的里程碑.
- 在TIL制造方面的进步,包括新的培养技术和自动化,旨在提高可扩展性和有效性.
- 挑战仍然存在,包括高剂量互白素-2毒性,复杂的制造和瘤免疫逃避.
结论:
- 新兴的策略,如检查点抑制剂组合,工程TIL和代谢重编程正在开发中,以提高TIL的疗效.
- TIL疗法具有显著的潜力,可以改善现有的癌症免疫治疗方法.
- 持续的研究和开发对于优化TIL治疗的临床应用和克服其局限性至关重要.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


